Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

OCTAVIA trial: bevacizumab and paclitaxel treatment for ovarian cancer

Dr Antonio Gonzalez-Martin – MD Anderson Cancer Center, Madrid, Spain
OCTAVIA trial: bevacizumab and paclitaxel treatment for ovarian cancer ( Dr Antonio Gonzalez-Martin – MD Anderson Cancer Center, Madrid, Spain )
30 Oct 2012

Study of ovarian cancer and endometriosis sub-fertility

Prof Curt Burger – Erasmus University, Rotterdam, Netherlands
Study of ovarian cancer and endometriosis sub-fertility ( Prof Curt Burger – Erasmus University, Rotterdam, Netherlands )
29 Oct 2012

Sexual health during and after ovarian cancer treatment

Dr Susan Carr – Royal Women’s Hospital, Parkville, Australia
Sexual health during and after ovarian cancer treatment ( Dr Susan Carr – Royal Women’s Hospital, Parkville, Australia )
29 Oct 2012

Treating platinum resistant ovarian cancer

Dr Andres Poveda – Fundacion Instituto Valenciano de Oncologia, Spain
Treating platinum resistant ovarian cancer ( Dr Andres Poveda – Fundacion Instituto Valenciano de Oncologia, Spain )
12 Oct 2012

Hepatic chemosaturation therapy

Dr Krishna Kandarpa – Delcath Systems Inc, Dr Pier Ferrucci – European Insitute of Oncology, Milan, Italy
Hepatic chemosaturation therapy ( Dr Krishna Kandarpa – Delcath Systems Inc, Dr Pier Ferrucci – European Insitute of Oncology, Milan, Italy )
11 Oct 2012

Analysing the efficacy of treatment through Response Evaluation Criteria in Solid Tumors (RECIST)

Dr Yves Menu – Saint Antoine Hospital, Paris, France
Analysing the efficacy of treatment through Response Evaluation Criteria in Solid Tumors (RECIST) ( Dr Yves Menu – Saint Antoine Hospital, Paris, France )
9 Oct 2012

Treatment approaches for desmoid tumours

Dr Sylvie Bonvalot – Institut Gustave Roussy, Paris, France
Treatment approaches for desmoid tumours ( Dr Sylvie Bonvalot – Institut Gustave Roussy, Paris, France )
9 Oct 2012

Standard of care for neo-adjuvant therapy in HER 2 and triple negative subtype

Dr Fatima Cardoso – Champalimaud Cancer Center, Lisbon, Portugal
Standard of care for neo-adjuvant therapy in HER 2 and triple negative subtype ( Dr Fatima Cardoso – Champalimaud Cancer Center, Lisbon, Portugal )
9 Oct 2012

The Neo ALTO Study, combination therapy of lapatinib and trastuzumab and breast conservation surgery

Dr Carmen Criscitiello - European Institute of Oncology, Milan, Italy
The Neo ALTO Study, combination therapy of lapatinib and trastuzumab and breast conservation surgery ( Dr Carmen Criscitiello - European Institute of Oncology, Milan, Italy )
9 Oct 2012

Multidisciplinary benefits to radiotherapy

Prof Vincenzo Valentini – President of ESTRO
Multidisciplinary benefits to radiotherapy ( Prof Vincenzo Valentini – President of ESTRO )
9 Oct 2012

Treatment of ALK+ lung cancer with crizotinib, Profile 1007

Dr Alice Shaw – Massachusetts General Hospital, Boston, USA
Treatment of ALK+ lung cancer with crizotinib, Profile 1007 ( Dr Alice Shaw – Massachusetts General Hospital, Boston, USA )
8 Oct 2012

Trametinib and dabrafenib combination therapy against metastatic melanoma

Dr Georgina Long – Westmead Hospital, The University of Sydney, Australia
Trametinib and dabrafenib combination therapy against metastatic melanoma ( Dr Georgina Long – Westmead Hospital, The University of Sydney, Australia )
8 Oct 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation